• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Diseases & Conditions

  • All Diseases and Conditions

The following clinical trials are associated with All diseases and conditions.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • expand The asthma control rate achieved by budesonide/formoterol in clinical practice in China
    Study Id
    NIS-RCN-SYM-2012/1
    Disease
    asthma
    Drug Name
    non drug study (respiratory)
    Study Name
    NIS-RCN-SYM-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes
    Study Id
    D1693C00001
    Disease
    myocardial infarction
    Drug Name
    dapagliflozin
    Study Name
    D1693C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A cohort study with a nested case control analysis on the association between acid-suppressing drugs and seizures using THIN database in the UK.
    Study Id
    D9612N00017
    Disease
    epidemiology
    Drug Name
    non drug study (gastrointestinal)
    Study Name
    D9612N00017
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Clinical Experience Investigation
    Study Id
    D961HC00010
    Disease
    gastroenterology
    Drug Name
    Nexium, esomeprazole
    Study Name
    D961HC00010
    Recruiting Status
    Open
    Protocol
    Apr 29, 2013
    • D961HC00010 (240 KB)
    Report Status
    Not Available
  • expand A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia
    Study Id
    D3720C00002
    Disease
    bacterial infection
    Study Name
    D3720C00002
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Nexium capsules Specific Clinical Experience Investigation for long-term use concerning prevention of recurrence of gastric ulcer or duodenal ulcer with LDA
    Study Id
    D961PC00002
    Disease
    duodenal ulcer, gastric ulcer
    Drug Name
    AstraZeneca Gastrointestinal Brands
    Study Name
    NIS-GJP-NEX-2012/1
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-label Study to Assess the Safety and Tolerability of Doses of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
    Study Id
    D081BC00001
    Disease
    solid tumour
    Drug Name
    Olaparib
    Study Name
    D081BC00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Evaluation of sub-syndromal symptoms after acute depressive episode in bipolar disorder.
    Study Id
    NIS-NFR-XXX-2012/1
    Disease
    bipolar disorder
    Drug Name
    non drug study (neuroscience)
    Study Name
    Polaris
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Selumetinib (AZD6244; ARRY-142886) in Combination With First Line Chemotherapy Regimens in Patients With Non-Small Cell Lung Cancer (NSCLC)
    Study Id
    D1532C00070
    Disease
    non-small cell lung cancer
    Drug Name
    AZD6244
    Study Name
    D1532C00070
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Specific Clinical Experience Investigation for long-term use of exenatide (Byetta subcutaneous injection).
    Study Id
    D5550C00001
    Disease
    diabetes type 2
    Drug Name
    AstraZeneca Cardiovascular Brands
    Study Name
    D5550C00001
    Recruiting Status
    Open
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013